Cu/Zn superoxide dismutase (SOD1) mutations associated with familial amyotrophic lateral sclerosis (ALS) affect cellular free radical release in the presence of oxidative stress

被引:43
|
作者
Cookson, MR
Menzies, FM
Manning, P
Eggett, CJ
Figlewicz, DA
McNeil, CJ
Shaw, PJ
机构
[1] Univ Sheffield, Sch Med, Dept Neurol, Acad Neurol Unit, Sheffield S10 2RX, S Yorkshire, England
[2] Univ Newcastle Upon Tyne, Dept Clin Biochem, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England
[3] Univ Rochester, Dept Neurol & Neurobiol & Anat, Rochester, NY 14627 USA
来源
AMYOTROPHIC LATERAL SCLEROSIS AND OTHER MOTOR NEURON DISORDERS | 2002年 / 3卷 / 02期
关键词
amyotrophic lateral sclerosis; SOD1; mutations; nitric oxide; superoxide; neuroprotection;
D O I
10.1080/146608202760196048
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Introduction: The exact molecular mechanisms by which mutations in Cu/Zn superoxide dismutase (SOD1) cause motor neuron injury remain incompletely understood, though a body of evidence suggests that the mutant protein exerts a cell-specific toxic gain of function. The role of nitric oxide (NO) in SOD1-related motor neuron injury has been particularly controversial. Theoretically, there are arguments to suggest that NO may exert an important role in motor neuron injury, but there is relatively little direct experimental support for this hypothesis. Objectives: The present study aimed to examine further the potential role for NO in motor neuron injury caused by mutant SOD1. Method: We have generated a cellular model of familial amyotrophic lateral sclerosis (ALS) by stably transfecting NSC34 cells with one of three mutant forms of SOD1 (G93A, G37R, I113T). In the presence of mutant SOD1, NSC34 cells show increased cell death following oxidative stress induced by serum withdrawal. This model of motor neuron death involves cellular release of superoxide and NO radicals, which were directly measured in real time using microelectrode biosensors. Results: The expression of both normal and mutant SOD1 decreased the measured extracellular superoxide release, but had divergent effects on the measured release of NO. Normal SOD1 increased the measured NO release, whereas cells expressing mutant SOD1 released less NO. Co-administration of two different nitric oxide synthase inhibitors (L-NAME and L-N-methyl arginine) did show some neuroprotective effect, but this was only partial, and the effect was more marked using nuclear integrity as a measure of cell viability, rather than MTT conversion. Cells expressing mutant SOD1 were, however, more sensitive to toxicity induced by extrinsic exposure to NO, using a slow-release NO donor. Conclusion: NO is likely to contribute to motor neuron injury, but this does not fully account for all the cellular toxic effects of mutant SOD1.
引用
收藏
页码:75 / 85
页数:11
相关论文
共 50 条
  • [1] Amyotrophic lateral sclerosis: copper/zinc superoxide dismutase (SOD1) gene mutations
    Orrell, RW
    NEUROMUSCULAR DISORDERS, 2000, 10 (01) : 63 - 68
  • [2] Selective loss of neurofilament expression in Cu/Zn superoxide dismutase (SOD1) linked amyotrophic lateral sclerosis
    Menzies, FM
    Grierson, AJ
    Cookson, MR
    Heath, PR
    Tomkins, J
    Figlewicz, DA
    Ince, PG
    Shaw, PJ
    JOURNAL OF NEUROCHEMISTRY, 2002, 82 (05) : 1118 - 1128
  • [3] Silence superoxide dismutase 1 (SOD1): a promising therapeutic target for amyotrophic lateral sclerosis (ALS)
    Abati, Elena
    Bresolin, Nereo
    Comi, Giacomo
    Corti, Stefania
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2020, 24 (04) : 295 - 310
  • [4] Familial amyotrophic lateral sclerosis and Cu/Zn superoxide dismutase mutation
    Shibata, N
    Kobayashi, M
    NEUROPATHOLOGY, 1997, 17 (04) : 255 - 262
  • [5] Clinical characteristics of familial amyotrophic lateral sclerosis with Cu/Zn superoxide dismutase gene mutations
    Abe, K
    Aoki, M
    Ikeda, M
    Watanabe, M
    Hirai, S
    Itoyama, Y
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 1996, 136 (1-2) : 108 - 116
  • [6] Stabilization of mutant Cu/Zn superoxide dismutase (SOD1) protein by coexpressed wild SOD1 protein accelerates the disease progression in familial amyotrophic lateral sclerosis mice
    Fukada, K
    Nagano, S
    Satoh, M
    Tohyama, C
    Nakanishi, T
    Shimizu, A
    Yanagihara, T
    Sakoda, S
    EUROPEAN JOURNAL OF NEUROSCIENCE, 2001, 14 (12) : 2032 - 2036
  • [7] Superoxide dismutase mutations of familial amyotrophic lateral sclerosis and the oxidative inactivation of calcineurin
    Volkel, H
    Scholz, M
    Link, J
    Selzle, M
    Werner, P
    Tunnemann, R
    Jung, G
    Ludolph, AC
    Reuter, A
    FEBS LETTERS, 2001, 503 (2-3) : 201 - 205
  • [8] Identification of a novel D109Y mutation in Cu/Zn superoxide dismutase (sod1) gene associated with amyotrophic lateral sclerosis
    Naini, Ali
    Mehrazin, Mahsa
    Lu, Jiesheng
    Gordon, Paul
    Mitsumoto, Hiroshi
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2007, 254 (1-2) : 17 - 21
  • [9] Current status of SOD1 mutations in familial amyotrophic lateral sclerosis
    Gaudette, M
    Hirano, M
    Siddique, T
    AMYOTROPHIC LATERAL SCLEROSIS, 2000, 1 (02): : 83 - 89
  • [10] Modification of Superoxide Dismutase 1 (SOD1) Properties by a GFP Tag - Implications for Research into Amyotrophic Lateral Sclerosis (ALS)
    Stevens, James C.
    Chia, Ruth
    Hendriks, William T.
    Bros-Facer, Virginie
    van Minnen, Jan
    Martin, Joanne E.
    Jackson, Graham S.
    Greensmith, Linda
    Schiavo, Giampietro
    Fisher, Elizabeth M. C.
    PLOS ONE, 2010, 5 (03): : A8 - A17